OncLive® On Air cover image

S16 Ep11: Expert Illustrations & Commentaries: Translating the Science of Bispecific Antibodies in Solid Tumors – From Mechanisms to Emerging Data

OncLive® On Air

00:00

Vilrestimig and Catenilumab Overview

Anne S. Tsao reviews vilrestimig (Medi-5752) and catenilumab (AK-104) targeting PD-1/CTLA-4 and key trial contexts.

Play episode from 03:10
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
 Get the app